AtriCure PE Ratio 2010-2025 | ATRC
Current and historical p/e ratio for AtriCure (ATRC) from 2010 to 2025. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. AtriCure PE ratio as of July 16, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| AtriCure PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-07-16 | 30.38 | 0.00 | |
| 2025-03-31 | 32.26 | $-0.81 | 0.00 |
| 2024-12-31 | 30.56 | $-0.95 | 0.00 |
| 2024-09-30 | 28.04 | $-0.83 | 0.00 |
| 2024-06-30 | 22.77 | $-0.86 | 0.00 |
| 2024-03-31 | 30.42 | $-0.80 | 0.00 |
| 2023-12-31 | 35.69 | $-0.66 | 0.00 |
| 2023-09-30 | 43.80 | $-0.54 | 0.00 |
| 2023-06-30 | 49.36 | $-0.61 | 0.00 |
| 2023-03-31 | 41.45 | $-0.82 | 0.00 |
| 2022-12-31 | 44.38 | $-1.01 | 0.00 |
| 2022-09-30 | 39.10 | $-1.22 | 0.00 |
| 2022-06-30 | 40.86 | $1.16 | 35.22 |
| 2022-03-31 | 65.67 | $1.12 | 58.63 |
| 2021-12-31 | 69.53 | $1.07 | 64.98 |
| 2021-09-30 | 69.55 | $0.95 | 73.21 |
| 2021-06-30 | 79.33 | $-1.27 | 0.00 |
| 2021-03-31 | 65.52 | $-1.11 | 0.00 |
| 2020-12-31 | 55.67 | $-1.15 | 0.00 |
| 2020-09-30 | 39.90 | $-1.15 | 0.00 |
| 2020-06-30 | 44.95 | $-1.29 | 0.00 |
| 2020-03-31 | 33.59 | $-1.20 | 0.00 |
| 2019-12-31 | 32.51 | $-0.93 | 0.00 |
| 2019-09-30 | 24.94 | $-0.60 | 0.00 |
| 2019-06-30 | 29.84 | $-0.57 | 0.00 |
| 2019-03-31 | 26.79 | $-0.47 | 0.00 |
| 2018-12-31 | 30.60 | $-0.63 | 0.00 |
| 2018-09-30 | 35.03 | $-0.62 | 0.00 |
| 2018-06-30 | 27.05 | $-0.62 | 0.00 |
| 2018-03-31 | 20.52 | $-0.82 | 0.00 |
| 2017-12-31 | 18.24 | $-0.83 | 0.00 |
| 2017-09-30 | 22.37 | $-1.02 | 0.00 |
| 2017-06-30 | 24.25 | $-1.01 | 0.00 |
| 2017-03-31 | 19.15 | $-1.06 | 0.00 |
| 2016-12-31 | 19.57 | $-1.05 | 0.00 |
| 2016-09-30 | 15.82 | $-1.14 | 0.00 |
| 2016-06-30 | 14.13 | $-1.15 | 0.00 |
| 2016-03-31 | 16.83 | $-1.07 | 0.00 |
| 2015-12-31 | 22.44 | $-0.95 | 0.00 |
| 2015-09-30 | 21.91 | $-0.79 | 0.00 |
| 2015-06-30 | 24.64 | $-0.59 | 0.00 |
| 2015-03-31 | 20.49 | $-0.51 | 0.00 |
| 2014-12-31 | 19.96 | $-0.63 | 0.00 |
| 2014-09-30 | 14.72 | $-0.67 | 0.00 |
| 2014-06-30 | 18.38 | $-0.78 | 0.00 |
| 2014-03-31 | 18.81 | $-0.77 | 0.00 |
| 2013-12-31 | 18.68 | $-0.56 | 0.00 |
| 2013-09-30 | 10.98 | $-0.44 | 0.00 |
| 2013-06-30 | 9.50 | $-0.47 | 0.00 |
| 2013-03-31 | 7.92 | $-0.46 | 0.00 |
| 2012-12-31 | 6.90 | $-0.46 | 0.00 |
| 2012-09-30 | 7.44 | $-0.47 | 0.00 |
| 2012-06-30 | 9.61 | $-0.38 | 0.00 |
| 2012-03-31 | 9.95 | $-0.36 | 0.00 |
| 2011-12-31 | 11.10 | $-0.34 | 0.00 |
| 2011-09-30 | 9.74 | $-0.21 | 0.00 |
| 2011-06-30 | 12.90 | $-0.21 | 0.00 |
| 2011-03-31 | 11.38 | $-0.20 | 0.00 |
| 2010-12-31 | 10.27 | $-0.25 | 0.00 |
| 2010-09-30 | 7.87 | $-0.41 | 0.00 |
| 2010-06-30 | 6.65 | $-0.66 | 0.00 |
| 2010-03-31 | 5.89 | $-0.71 | 0.00 |
| 2009-12-31 | 6.04 | $-1.14 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.504B | $0.465B |
| AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative surgical devices to create precise lesions, or scars, in soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure, Inc. bipolar ablation system as a standard treatment alternative during open-heart surgical procedures to safely, rapidly and reliably create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, a quivering of the upper chambers of the heart. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $229.206B | 27.56 |
| Boston Scientific (BSX) | United States | $152.664B | 38.22 |
| Stryker (SYK) | United States | $149.191B | 31.19 |
| EssilorLuxottica (ESLOY) | France | $131.913B | 0.00 |
| Medtronic (MDT) | Ireland | $115.147B | 16.32 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.094B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.531B | 24.85 |
| ResMed (RMD) | United States | $37.280B | 28.00 |
| GE HealthCare Technologies (GEHC) | United States | $34.547B | 16.40 |
| Agilent Technologies (A) | United States | $32.221B | 21.01 |
| Terumo (TRUMY) | Japan | $24.355B | 31.64 |
| Koninklijke Philips (PHG) | Netherlands | $23.476B | 16.47 |
| Insulet (PODD) | United States | $20.287B | 79.63 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.641B | 11.97 |
| Baxter (BAX) | United States | $14.559B | 10.87 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.951B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $10.417B | 0.00 |
| Demant (WILYY) | Denmark | $8.633B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.729B | 23.42 |
| Lantheus Holdings (LNTH) | United States | $5.148B | 12.99 |
| Perrigo (PRGO) | Ireland | $3.724B | 9.44 |
| Prestige Consumer Healthcare (PBH) | United States | $3.715B | 16.59 |
| Haemonetics (HAE) | United States | $3.575B | 16.28 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.342B | 27.77 |
| ICU Medical (ICUI) | United States | $3.072B | 22.66 |
| LeMaitre Vascular (LMAT) | United States | $1.867B | 41.72 |
| QuidelOrtho (QDEL) | United States | $1.864B | 12.82 |
| Acuren (TIC) | United States | $1.431B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.238B | 15.82 |
| AdaptHealth (AHCO) | United States | $1.232B | 12.51 |
| Green Thumb Industries (GTBIF) | United States | $1.212B | 27.26 |
| Neogen (NEOG) | United States | $1.068B | 13.67 |
| BioLife Solutions (BLFS) | United States | $1.006B | 0.00 |
| InMode (INMD) | Israel | $0.901B | 9.08 |
| Kestra Medical Technologies (KMTS) | United States | $0.788B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.670B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.642B | 0.00 |
| Owens & Minor (OMI) | United States | $0.613B | 5.08 |
| Tilray Brands (TLRY) | Canada | $0.607B | 0.00 |
| Evolus (EOLS) | United States | $0.593B | 0.00 |
| CeriBell (CBLL) | United States | $0.571B | 0.00 |
| Valneva SE (VALN) | France | $0.552B | 0.00 |
| Surmodics (SRDX) | United States | $0.446B | 0.00 |
| SNDL (SNDL) | Canada | $0.392B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.331B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.321B | 11.82 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.304B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.300B | 0.00 |
| Quanterix (QTRX) | United States | $0.283B | 0.00 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.264B | 22.30 |
| Cresco Labs (CRLBF) | United States | $0.260B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.252B | 74.67 |
| Sanara MedTech (SMTI) | United States | $0.248B | 0.00 |
| ZimVie (ZIMV) | United States | $0.243B | 11.04 |
| OraSure Technologies (OSUR) | United States | $0.239B | 0.00 |
| Brainsway (BWAY) | Israel | $0.230B | 60.75 |
| Biote (BTMD) | United States | $0.224B | 6.31 |
| Omeros (OMER) | United States | $0.206B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.202B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.200B | 0.00 |
| High Tide (HITI) | Canada | $0.197B | 0.00 |
| Organigram Global (OGI) | Canada | $0.196B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.183B | 14.87 |
| TriSalus Life Sciences (TLSI) | United States | $0.178B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.152B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.123B | 15.16 |
| TerrAscend (TSNDF) | Canada | $0.101B | 0.00 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.100B | 12.87 |
| MacroGenics (MGNX) | United States | $0.096B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.090B | 0.00 |
| Veru (VERU) | United States | $0.088B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.086B | 0.00 |
| Apyx Medical (APYX) | United States | $0.079B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.069B | 0.00 |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Agape ATP (ATPC) | $0.068B | 0.00 | |
| Cytosorbents (CTSO) | United States | $0.065B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 14.76 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| Safety Shot (SHOT) | United States | $0.037B | 0.00 |
| Nephros (NEPH) | United States | $0.037B | 49.29 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.022B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.014B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |